My take on the most important findings in RA prevention and treatment presented at the virtual EULAR 2020 E-Congress.
My take on the most important findings regarding efficacy and safety of JAK inhibitors in RA presented at the virtual EULAR 2020 E-Congress.
My thoughts on recent studies of RA and ILD, fatigue, and cancer presented at the virtual EULAR 2020 E-Congress.
What to do in biologic-experienced patients with RA? Here’s my take.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.